Biotech Rose as Covid Spread. Now It's Falling Behind
March 19, 2021 at 06:00 AM EDT
The S&P 500 Biotech index rose as much as 25% last year after falling as low as 8% during the apex of last year’s sell-offs. Now, downward pressure is helping leveraged inverse funds like the Direxion Daily S&P Biotech Bear 3X Shares ( LABD ).